Please provide your email address to receive an email when new articles are posted on . Less than 10% of adults receiving tirzepatide in clinical trials reported a serious adverse event.

The world’s most commonly prescribed opioid for pain has been shown to offer limited relief benefits while elevating the risk ...

The FDA has placed a clinical hold on Novavax’s application for its COVID-19-Influenza combination and standalone influenza vaccine candidates following a report of a “serious adverse event.” The ...

One in ten patients experience a “serious adverse event” after taking the abortion pill, according to a study released Monday by the Ethics and Public Policy Center (EPPC), a conservative think tank ...

Patients given ester-based local anesthetics may be at greater risk of having serious complications when they are administered numbing agents, according to a study published on March 31 in the ...

The Institute for Healthcare Improvement offers a free, downloadable toolkit to help healthcare organizations prepare for a response to a serious adverse event. The toolkit was developed by Christiana ...

In a regulatory filing, Soleno Therapeutics (SLNO) disclosed that it is aware that a serious adverse event has been reported in the U.S. Food and Drug Administration’s Adverse Event Reporting System, ...

Nearly a quarter of stays among an 11-hospital sample of roughly 2,800 admissions included at least one adverse event, and about 7% of admissions included an adverse event that could have been ...

Per federal regulations, University and affiliate researchers must notify the IRB of unanticipated problems that involve risks to participants or others (henceforth referenced as Unanticipated ...